Dynasty Wealth Management LLC cut its holdings in Avantor, Inc. (NYSE:AVTR – Free Report) by 38.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 34,019 shares of the company’s stock after selling 21,251 shares during the quarter. Dynasty Wealth Management LLC’s holdings in Avantor were worth $717,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Public Employees Retirement System of Ohio increased its stake in shares of Avantor by 34.1% in the third quarter. Public Employees Retirement System of Ohio now owns 346,822 shares of the company’s stock valued at $8,972,000 after buying an additional 88,205 shares in the last quarter. Perpetual Ltd increased its position in Avantor by 38.7% in the 4th quarter. Perpetual Ltd now owns 1,766,882 shares of the company’s stock valued at $37,228,000 after acquiring an additional 493,408 shares in the last quarter. New York State Teachers Retirement System acquired a new stake in shares of Avantor in the third quarter valued at approximately $8,473,000. Everence Capital Management Inc. acquired a new stake in shares of Avantor in the fourth quarter valued at approximately $555,000. Finally, Rhumbline Advisers increased its holdings in shares of Avantor by 1.8% in the fourth quarter. Rhumbline Advisers now owns 1,922,368 shares of the company’s stock valued at $40,504,000 after purchasing an additional 33,692 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In other news, EVP James Bramwell sold 3,758 shares of the company’s stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $65,877.74. Following the completion of the transaction, the executive vice president now directly owns 87,379 shares of the company’s stock, valued at $1,531,753.87. This represents a 4.12 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Steven W. Eck sold 4,907 shares of the company’s stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $86,019.71. Following the transaction, the chief accounting officer now directly owns 40,604 shares of the company’s stock, valued at approximately $711,788.12. This trade represents a 10.78 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.50% of the company’s stock.
Analyst Ratings Changes
Get Our Latest Stock Report on Avantor
Avantor Stock Up 1.3 %
Shares of NYSE AVTR opened at $16.71 on Friday. Avantor, Inc. has a 52-week low of $16.41 and a 52-week high of $28.00. The stock has a market cap of $11.37 billion, a P/E ratio of 16.06, a P/E/G ratio of 1.55 and a beta of 1.28. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.70 and a current ratio of 1.07. The firm has a 50 day moving average price of $20.51 and a 200 day moving average price of $22.69.
Avantor (NYSE:AVTR – Get Free Report) last posted its earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same period in the previous year, the business earned $0.22 earnings per share. Analysts expect that Avantor, Inc. will post 1.06 EPS for the current year.
Avantor Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Read More
- Five stocks we like better than Avantor
- Using the MarketBeat Stock Split Calculator
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 5 Best Gold ETFs for March to Curb Recession Fears
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.